Table 1 Clinicopathological factors of included patients

From: Tertiary lymphoid structures associated with improved survival and enhanced antitumor immunity in acral melanoma

Factors

N = 46

Age, year

Median (range)

68 (43–86)

Sex, No (%)

Male

22 (47.8)

Female

24 (52.2)

TNM Stage, No (%)

I

5 (10.8)

II

22 (47.8)

III

19 (41.4)

Follow-up time, month

Median (range)

31.4 (7.7-124)

TLSs, No (%)

With

41 (89.1)

Without

5 (10.9)

Intratumoral TLSs, No (%)

With

25 (54.3)

Without

21 (45.7)

Peritumoral TLSs, No (%)

With

39 (84.8)

Without

7 (15.2)

Back to article page